GENENTA SCIENCE SPA
๐ฎ๐นItaly
- Country
- ๐ฎ๐นItaly
- Ownership
- Public
- Established
- 2014-01-01
- Employees
- 14
- Market Cap
- $74.3M
- Website
- http://www.genenta.com
A Clinical Gene Therapy Study with Hematopoietic Stem Cells for the Treatment, with Single Dose of Temferon, of Patients Suffering from Metastatic Renal Cell Carcinoma
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-12-04
- Last Posted Date
- 2024-12-04
- Lead Sponsor
- Genenta Science
- Target Recruit Count
- 12
- Registration Number
- NCT06716853
- Locations
- ๐ฎ๐น
Ospedale San Raffaele, Milan, Italy
A Phase I/II Study Evaluating Temferon in Multiple Myeloma Patients With Early Relapse After Front Line Therapy (TEM-MM)
- First Posted Date
- 2019-03-14
- Last Posted Date
- 2022-01-28
- Lead Sponsor
- Genenta Science
- Target Recruit Count
- 9
- Registration Number
- NCT03875495
- Locations
- ๐ฎ๐น
Ospedale San Raffaele, Milan, Italy
A Study Evaluating Temferon in Patients With Glioblastoma & Unmethylated MGMT
- First Posted Date
- 2019-03-07
- Last Posted Date
- 2023-01-20
- Lead Sponsor
- Genenta Science
- Target Recruit Count
- 27
- Registration Number
- NCT03866109
- Locations
- ๐ฎ๐น
Ospedale San Raffaele, Milan, Italy
๐ฎ๐นPoliclinico Universitario Fondazione Agostino Gemelli, Rome, Italy
๐ฎ๐นFondazione IRCCS Istituto Neurologico "Carlo Besta", Milan, Italy
ยฉ Copyright 2024. All Rights Reserved by MedPath